New Delhi [India], April 8 (ANI/PNN): Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced AcrySof® IQPanOptix® Trifocal Intraocular Lens (IOL) has surpassed more than one million implants worldwide. To mark this milestone, Alcon is laun
Mumbai (Maharashtra) [India], March 25 (ANI/BusinessWire India): Veeva Systems (NYSE: VEEV) today announced one of India's fastest-growing biopharma companies, Bharat Serums and Vaccines Limited (BSV), is standardizing on Veeva Vault PromoMats to accelerate its end-to-end content lifecycle f
New Delhi [India], March 18 (ANI): Pune-based Gennova Biopharmaceuticals has submitted the phase-II and phase-III trials data of India's first mRNA COVID vaccine to the regulator Drugs Controller General of India (DCGI) on Friday, said sources.
Mumbai (Maharashtra) [India], March 8 (ANI/PR Newswire): Ankura Consulting, LLC ("Ankura"), leading global expert services and advisory firm, today announced the expansion of its Pharmaceutical and Biopharma Regulatory Compliance offering with the addition of a Pharmaceutical Data Integrity
New Delhi [India], January 17 (ANI): The testing of Gennova Biopharmaceutical's mRNA vaccine for the Omicron variant of COVID-19 is subject to regulatory approvals, the company's official spokesperson informed on Monday.
Telangana (Hyderabad) [India]/Nanjing [China], December 1 (ANI/PR Newswire): Excelra, a leading global data & analytics provider, today announced its partnership with Silexon AI Technology, a next-generation biotech company with a scalable AI/ML (Artificial Intelligence and Machine Learn
Seoul [South Korea], November 9 (ANI/Global Economic): Prestige Biopharma announced that it has signed a technology transfer contract with HV (Human Vaccine), a subsidiary of the Russian Direct Investment Fund (RDIF), and ENSO (ENSO Healthcare DMCC), a Sputnik vaccine production partner, to
Bengaluru (Karnataka) [India]/ Saratoga (California) [US]/ Adelaide [Australia], November 8 (ANI/PRNewswire): Bugworks research today announced that the first human dose was administered in a Phase 1 clinical trial evaluating BWC0977: a next generation broad-spectrum, novel bacterial topoiso
Washington [US], November 6 (ANI): The Medical College of Georgia scientists have early evidence that HBI-002, a low-dose oral compound developed by Hillhurst Biopharmaceuticals and already in early-stage trials for sickle cell disease, can safely reduce oxidative stress and inflammation in
Seoul [South Korea], November 4 (ANI/Global Economic): Global biopharmaceutical raw and subsidiary material suppliers are announcing investment plans in Korea. As companies convert to 'local production' strategy due to the shortage of bio-materials, components, and equipment during the pande
Hyderabad (Telangana) [India], October 1 (ANI/PRNewswire): Informa Pharma Intelligence, one of the leading business intelligence providers and knowledge partners, has today concluded the 3rd edition of the Biopharma Conclave conducted by CPhI.